What Researchers Did
The authors described one patient with moderate jaw bone death linked to bisphosphonate drugs and discussed how surgery, platelet-rich plasma, hyperbaric oxygen therapy and stopping the drug might fit into care.
What They Found
This case report describes one person with moderate osteonecrosis of the upper jaw that was induced by bisphosphonates, and it discusses a possible role for combined management. The abstract gives no numbers, no outcome measures and no HBOT protocol details such as pressure or number of sessions. It says there is no consensus on an ideal treatment for this condition. It also says that preventing jaw osteonecrosis is the standard goal that researchers agree on, and that current treatment has proven to be suboptimal.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a single case report with no comparison group and no reported results, and because several treatments were discussed together, the abstract cannot show which one, if any, made a difference.